High Vista Strategies LLC Forma Therapeutics Holdings, Inc. Transaction History

High Vista Strategies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$8.34 - $14.69 $338,704 - $596,590	-40,612 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$13.6 - $24.89 $189,053 - $345,995	13,901 Added 52.04%	40,612 $578,000
Q3 2021 Nov 15, 2021	SELL	$21.22 - $25.7 $41,888 - $50,731	-1,974 Reduced 6.88%	26,711 $619,000
Q2 2021 Aug 16, 2021	BUY	$22.86 - $30.95 $184,137 - $249,302	8,055 Added 39.05%	28,685 $714,000
Q1 2021 May 17, 2021	BUY	$24.58 - $42.82 $58,451 - $101,825	2,378 Added 13.03%	20,630 $578,000
Q4 2020 Feb 16, 2021	BUY	$34.9 - $51.08 $206,852 - $302,751	5,927 Added 48.09%	18,252 $637,000
Q3 2020 Nov 16, 2020	BUY	$32.95 - $50.25 $406,108 - $619,331	12,325 New	12,325 $614,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.